18 first imitations of the most competitive varieties in the first half of 2014
-
Last Update: 2014-07-08
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: QXI Sina blog, July 8, 2014, generic name, indication and imitation manufacturer: tofetib rheumatoid arthritis, Jiangsu Xiansheng, Zhengda Tianqing, aosaikang, Sichuan Kelun, Tianjin hankang, Shiyao group, kefeiping, Guangzhou egger, China Resources SECCO parixib, postoperative pain Hunan Kelun, Jiangsu Hengrui, Qilu pharmaceutical, aosaikang, Shandong Luoxin, Kangenbei, Hunan Cylon, Tianjin hanruiapixaban to prevent thrombus Nanjing runnuo, Jiangxi Qingfeng, Cavendish, Zhengda Tianqing, Qilu pharmaceutical, Jiangsu Haosen, Shenghua xilivaxaban to prevent thrombus Qilu pharmaceutical, Jiangsu Haosen, Shiyao group, Nanjing Youke, Hangzhou Heze, kofipin pomadomide multiple myeloma, Jiangsu Haosen, Jiangsu Xiansheng, aosaikang, Nanjing Warwick, Zhengda Tianqing afanafei erectile dysfunction, Tianjin hankang, Taizhou Jinhong, Guangzhou egger, Guangzhou Langsheng, Jiangxi Qingfeng solafeni liver cell carcinoma Jiangsu Haosen, Qilu pharmaceutical, Petrochemicals Group, Hunan Kelun, Shandong Luoxin caglejing type II diabetes, Jiangsu Haosen, Sichuan Kelun, Yangzi River, Zhengda Tianqing axitini renal cell carcinoma, Sichuan Kelun, Qilu pharmaceutical, Jiangsu Haosen, Hefei Tuorui asenapine schizophrenics, Sichuan Kelun, Tianjin hankang, Nanjing Huawei Akotidine functional dyspepsia prevention of thrombus by Jiangsu Haosen, Sichuan Dikang, Shandong chengchuang, adekatenbergate Nanjing Huawei, Jiangsu Haosen, Qilu pharmaceutical, afatinifer small cell lung cancer Sichuan Kelun, Shiyao group, Jiangsu Haosen pazopani renal cell cancer Qilu pharmaceutical, osekang, Jiangsu Haosen pishanqiong Non Hodgkin's lymphoma: Jiangsu Haosen, Zhengda Tianqing, Nanjing Huawei pirastine allergic rhinitis: Nanjing Huawei, Tianjin hankang, Chongqing Huabang yidushaban to prevent thrombosis: Shijiazhuang establishment, Shijiazhuang Zhiheng, Ruiyang Pharmaceutical Co., Ltd tigriluo acute coronary syndrome: Jiangsu Hengrui, Shiyao group, Zhengda Tianqing
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
